Newbridge Financial Services Group, Inc. - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 47 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2021. The put-call ratio across all filers is 3.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
Newbridge Financial Services Group, Inc. ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$1,0003120.0%0.00%
Q1 2022$0
-100.0%
3120.0%0.00%
Q4 2021$1,0000.0%3120.0%0.00%
-100.0%
Q3 2021$1,000
-50.0%
3120.0%0.00%0.0%
Q2 2021$2,000
-33.3%
3120.0%0.00%
-50.0%
Q1 2021$3,000
+200.0%
3120.0%0.00%
+100.0%
Q4 2020$1,0003120.0%0.00%
Q3 2020$03120.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q2 2021
NameSharesValueWeighting ↓
WealthTrust Axiom LLC 11,561$21,0000.01%
Tower Research Capital LLC (TRC) 38,887$73,0000.00%
Newbridge Financial Services Group, Inc. 312$1,0000.00%
Stonebridge Financial Planning Group, LLC 375$1,0000.00%
Squarepoint Ops LLC 15,680$29,0000.00%
OSAIC HOLDINGS, INC. 808$1,0000.00%
US BANCORP \DE\ 1,000$2,0000.00%
WELLS FARGO & COMPANY/MN 86$00.00%
NORTHERN TRUST CORP 16,192$30,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders